Prenetics

PRE

Hong Kong, Hong Kong· Est. 2014

prenetics.com

Is this your company? Claim your profile to update info and connect with investors.

Claim profile

PRE · Stock Price

USD 15.87+10.48 (+194.54%)

Market Cap: $268.4M

Historical price data

Overview

Prenetics is a publicly-traded health sciences company executing a bold pivot from its roots in COVID-19 testing and genetic diagnostics to focus on high-growth consumer health. Its core achievement is the launch of IM8, a premium supplement brand developed with David Beckham, which reached $120M in Annual Recurring Revenue within 12 months, marking it as one of the fastest-growing brands in the industry. The company's strategy is to leverage its scientific credibility and capital to build IM8 into a global category leader in core nutrition and longevity, while maintaining a strong, debt-free balance sheet.

Consumer HealthLongevityWellness

Technology Platform

Leverages a legacy of diagnostic lab infrastructure and scientific advisory rigor to develop and validate a direct-to-consumer digital platform for premium supplement products, powered by high-profile celebrity partnerships.

Opportunities

The global consumer health and longevity supplement market is vast and growing, with a strong trend towards premium, science-backed products.

Prenetics' IM8 brand has demonstrated a unique ability to achieve rapid scale through celebrity partnership and digital execution, positioning it to capture significant market share.

Risk Factors

Key risks include the high execution risk of a full business model pivot, potential fickleness of consumer brand loyalty, regulatory scrutiny of supplement claims, and intense competition that could drive unsustainable customer acquisition costs.

Competitive Landscape

Prenetics competes in the crowded premium D2C supplement space against brands like AG1 and Hims & Hers, differentiating via its elite celebrity co-founders and aggressive longevity science positioning. In its legacy diagnostics segment, it faces low-margin competition from other lab service providers.